Rui Zhang1, Jie Wu2, Hang Ao2, Jinling Fu1, Bin Qiao1, Qiang Wu1, Huangxian Ju2. 1. School of Tropical Medicine and Laboratory Medicine, Key Laboratory of Emergency and Trauma of Ministry of Education, Hainan Medical University, Haikou 571199, China. 2. State Key Laboratory of Analytical Chemistry for Life Science, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing 210023, China.
Abstract
Sensitive detection of the SARS-CoV-2 protein remains a great research interest in clinical screening and diagnosis owing to the coronavirus epidemic. Here, an ultrasensitive chemiluminescence (CL) imaging strategy was developed through proximity hybridization to trigger the formation of a rolling circle-amplified G-quadruplex/hemin DNAzyme for the detection of the SARS-CoV-2 protein. The target protein was first recognized by a pair of DNA-antibody conjugates, Ab-1 and Ab-2, to form a proximity-ligated complex, Ab-1/SARS-CoV-2/Ab-2, which contained a DNA sequence complemental to block DNA and thus induced a strand displacement reaction to release the primer from a block/primer complex. The released primer then triggered a rolling circle amplification to form abundant DNAzyme units in the presence of hemin, which produced a strong chemiluminescent signal for the detection of the target protein by catalyzing the oxidation of luminol by hydrogen peroxide. The proposed assay showed a detectable concentration range over 5 orders of magnitude with the detection limit down to 6.46 fg/mL. The excellent selectivity, simple procedure, acceptable accuracy, and intrinsic high throughput of the imaging technique for analysis of serum samples demonstrated the potential applicability of the proposed detection method in clinical screening and diagnosis.
Sensitive detection of the SARS-CoV-2 protein remains a great research interest in clinical screening and diagnosis owing to the coronavirus epidemic. Here, an ultrasensitive chemiluminescence (CL) imaging strategy was developed through proximity hybridization to trigger the formation of a rolling circle-amplified G-quadruplex/hemin DNAzyme for the detection of the SARS-CoV-2 protein. The target protein was first recognized by a pair of DNA-antibody conjugates, Ab-1 and Ab-2, to form a proximity-ligated complex, Ab-1/SARS-CoV-2/Ab-2, which contained a DNA sequence complemental to block DNA and thus induced a strand displacement reaction to release the primer from a block/primer complex. The released primer then triggered a rolling circle amplification to form abundant DNAzyme units in the presence of hemin, which produced a strong chemiluminescent signal for the detection of the target protein by catalyzing the oxidation of luminol by hydrogen peroxide. The proposed assay showed a detectable concentration range over 5 orders of magnitude with the detection limit down to 6.46 fg/mL. The excellent selectivity, simple procedure, acceptable accuracy, and intrinsic high throughput of the imaging technique for analysis of serum samples demonstrated the potential applicability of the proposed detection method in clinical screening and diagnosis.
Since the outbreak
of the coronavirus epidemic in 2019, severe
acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) has spread
at an unprecedented speed and scale.[1−3] The high fatality rate
of SARS-CoV-2 and its susceptibility of infection result in an urgent
need for sensitive and convenient detection methods for early and
prompt screening and diagnosis of this disease to effectively control
the dissemination of this infection. The general detection methods
of SARS-CoV-2 include real-time polymerase chain reaction (RT-PCR)
for the virus gene[4] and immunoassay for
SARS-CoV-2-related proteins. The latter can be performed with enzyme-linked
immunosorbent assay (ELISA),[5] gold immunochromatographic
assay (GICA),[6] and chemiluminescence immunoassay
(CLIA).[7] Although RT-PCR is a current standard
method for SARS-CoV-2 diagnosis due to its high precision and specificity,[8,9] some data indicate that this detection technique is not suitable
for all cases with clinical features of SARS-CoV-2, and serologic
assay has become an indispensable tool as a complementary method for
accurate diagnosis.[10] In serologic assay,
commercially available ELISA is considered as a reliable detection
method, but its efficiency is limited by laborious and time-consuming
operation. Although a GICA-based method is convenient and time-saving
for SARS-CoV-2 detection, its low detection sensitivity is not satisfactory
for early and prompt screening of this disease.[11,12] Therefore, developing a convenient assay for the SARS-CoV-2 protein
with high sensitivity is still an urgent need for epidemic diagnosis.Benefiting from the advantage of the light emission produced by
a specific chemical reaction, chemiluminescence (CL) can avoid the
interference of autofluorescence from the biological specimen or stray
excitation light, which normally exists in fluorescence-based assays
for direct analysis of serum samples.[13] Thus, CL assay is considered as an ideal method for serologic assays[14−16] and has been used for immunological testing of SARS-CoV-2 infection.[17] Moreover, this technique possesses outstanding
sensitivity, simple operation, and high throughput and can even be
used for in vitro or in vivo imaging without a need for additional
light sources.[18] More importantly, the
CL technique can be conveniently combined with a flow injection technique
for automated analysis[19] and some amplification
strategies for further improving its sensitivity to meet the detection
needs for low abundance proteins. For example, by using horseradish
peroxidase or G-quadruplex DNA (G4)/hemin-functionalized gold nanoparticles
as a labeling tag, two sensitive CL imaging immunoassay methods have
been developed for detection of biomarkers.[20,21] The labeling tag can be conveniently amplified via a DNA-labeled
antibody, which is used for both recognizing the target protein and
extending the DNA scaffold via hybridization chain reaction (HCR)
for loading of MnTMPyP[22] or forming signal
switch via proximity hybridization for homogeneous CL bioanalysis.[23,24] Proximity hybridization has been used for formation of a G4/hemin
DNAzyme to perform CL imaging of target proteins in serum samples.[25]To achieve highly sensitive assay of the
SARS-CoV-2 protein with
high throughput, here, an amplified CL imaging strategy was developed
by combining proximity hybridization with rolling circle amplification
(RCA).[26] The amplified homogeneous CL imaging
system was performed with a pair of DNA–antibody conjugates
to recognize the SARS-CoV-2 protein, which formed a proximity-ligated
complex, Ab-1/SARS-CoV-2/Ab-2, to induce a strand displacement reaction
for releasing the primer from a designed block/primer complex. The
released primer then triggered RCA with a C-rich circular DNA as a
template to produce a duplicate sequence of G4,[27−29] which formed
abundant DNAzyme units in the presence of hemin to produce a strong
CL signal.[30−32] This strategy showed a specific response to the SARS-CoV-2
protein with a wide concentration range and a fg/mL-level detection
limit. Owing to the advantages of CL imaging analysis, the proposed
detection method possessed great promise for protein-related diagnosis.
Experimental
Section
Reagents and Materials
Hydrogen peroxide (30%), 200
mM PBS (pH 7.2) buffer solution, and all DNA oligonucleotides were
obtained from Sangon Biological Engineering Technology & Co.,
Ltd. (Shanghai, China). The DNA sequences are listed in Table S1. The recombinant SARS-CoV-2nucleocapsid
protein, SARS-CoV-2 vaccine, GICA test paper, and murine monoclonal
SARS-CoV-2 antibodies 8B1 (Ab1) and 9B3 (Ab2) were provided by FANTIBODY
(Chongqing, China). Hemin, luminol, maleimidobenzoic acid N-hydroxy succinimide ester (MBS), dimethyl sulfoxide (DMSO),
and tris(2-carboxyethyl)phosphine hydrochloride (TCEP) were purchased
from Sigma-Aldrich (St Louis, MO, USA). A silver-staining kit and
a BCA protein kit were purchased from Biyuntian Biotechnology Co.,
Ltd. (Shanghai, China). An exonuclease III (Exo III), a DNA splint
R ligase, a phi 29 DNA polymerase, and their corresponding buffers
along with dNTP and BSA were bought from New England BioLabs (Beverly,
MA, USA). An RCA reaction solution was freshly prepared by mixing
the phi 29 DNA polymerase, dNTP, BSA, and its buffer in the ratios
of 1:4:2:2 (v:v:v:v). All reagents were of analytical grade without
further depuration. Ultrapure water from a Millipore water purification
system was used for all experiments. The storing solutions of hemin
(100 mM) and MBS (6.4 mM) were prepared by dispersing them into DMSO.
Apparatus
Polyacrylamide gel electrophoresis (PAGE)
analysis was carried out with an electrophoresis analyzer (Bio-Rad,
USA) and a Bio-Rad ChemiDoc XRS (Bio-Rad, USA). Ultraviolet–visible
(UV–vis) absorption spectra were collected with a Varioskan
Flash multimode reader (Thermo Scientific, USA). CL imaging was performed
on a 96-well plate (Sangon Biological Engineering Technology &
Co., Ltd., Shanghai, China), and the images were collected using a
high-resolution cooled low-light CCD (BioImaging Systems ChemiHR 410
camera, UVP, USA).
Synthesis of DNA–Antibody Conjugates
According
to previous studies,[33,34] DNA–antibody conjugates
were prepared using MBS as a biofunctional connector. Antibody 1 (Ab1)
(1 mg/mL) and antibody 2 (Ab2) (1 mg/mL) were first treated with excess
40-fold M MBS in 20 μL of 10 mM PBS (pH 7.2) for 2 h under low-frequency
vibration, and excess MBS was removed by ultrafiltration (50 kDa Millipore,
10,000 rpm) to obtain Ab1-MBS and Ab2-MBS, respectively. Meanwhile,
thiolated DNA 1 (24 μM) and DNA 2 (24 μM) were reduced
with 150-fold M TCEP in 100 μL of 10 mM PBS (pH 5.5) for 2 h,
and excess TCEP was removed by ultrafiltration (10 kDa Millipore,
12,000 rpm). Afterward, the reduced thiol-DNA 1 and thiol-DNA 2 were
respectively mixed with Ab1-MBS and Ab2-MBS to incubate for 2 h, respectively.
After unbound DNA 1 and DNA 2 were removed by ultrafiltration (100
kDa Millipore, 12,000 rpm), the concentrations of obtained DNA–antibody
conjugates, DNA 1-Antibody 1 (Ab-1) and DNA 2-Antibody 2 (Ab-2), were
quantized using a BCA protein kit. The above operations were performed
at room temperature, and the purified Ab-1 and Ab-2 were stored in
50 μL of 10 mM PBS (pH 7.2) at −20 °C.
Preparation
of Circular DNA
A G-padlock (10 μM)
and a primer (10 μM) were first mixed in 25 μL of 10 mM
PBS (pH 7.2) to anneal at 95 °C for 5 min, which was then slowly
cooled to 25 °C and mixed with 2 μL of a splint R ligase
(25 U/μL) and 3 μL of ligation buffer containing 500 mM
Tris-HCl, 100 mM MgCl2, 10 mM ATP, and 100 mM DTT to incubate
for 5 h at 25 °C with gentle vibration. After three times ultrafiltration,
3 μL of Exo III (100 U/μL) and 6 μL of exonucleolytic
buffer (CutSmart) were added in the product to adjust its volume with
10 mM PBS (pH 7.2) to 60 μL, which was then incubated at 37
°C for 5 h to obtain circular DNA and 65 °C for 20 min to
terminate the reaction. The obtained circular DNA was stored at 4
°C for further use.
PAGE and Silver-Staining Analysis
A polyacrylamide
gel (12%) was prepared with tris-borate-EDTA. The loading samples
were prepared by mixing 5 μL of DNA or proteins and 1 μL
of 5× loading buffer for 5 min incubation. After electrophoresis
analysis for 60 min at 110 V, DNA lands were stained by placing the
gel into a mixture containing nucleic acid fluorescent dye for 20
min and visualized with a molecular imager Gel XR, while the staining
of protein lands was carried out with a silver-staining kit after
being immobilized for 1 h with a mixture of 50% ethanol and 10% acetic
acid and visualized with a common camera.
The G4 structure was verified
with TDS measurement by recording
the UV-absorption spectra under the conditions of unfolding and folding
at temperatures above or below the melting temperature (Tm).[35] After measuring the absorption
spectra of nucleic acids at different temperatures, the absorbance
difference between 4 and 95 °C was calculated and used for forming
a vertical difference map.
CL Response to the Primer
After
0.5 μL solutions
containing different concentrations of the primer were mixed with
0.5 μL of circular DNA, 1.75 μL of PBS (10 mM, pH 7.2),
and 2.25 μL of the RCA reaction solution to incubate for 2 h
at 37 °C, 25 μL of PBS (10 mM) and 10 μL of hemin
(5 μM) were added in the mixtures to incubate in the dark at
room temperature for 20 min. A freshly prepared CL substrate mixture
(20 μL) (10 μL of 20 mM luminol and 10 μL of 10
mM H2O2) was then added to collect the CL images
with an exposure time of 30 s.
CL Imaging Detection of
the SARS-CoV-2 Protein
Solutions
(0.75 μL) containing different concentrations of the SARS-CoV-2
protein or the serum samples were first added in 4.25 μL of
the reaction mixture containing 0.5 μL of Ab-1 (10 ng/mL), 0.5
μL of Ab-2 (10 ng/mL), 0.5 μL of circular DNA, 0.5 μL
of the block/primer complex (10 nM), and 2.25 μL of the RCA
reaction solution to incubate for 2 h at 37 °C. Then, 25 μL
of PBS (10 mM) and 10 μL of hemin (5 μM) were added in
the mixture to incubate in the dark at room temperature for 20 min.
Afterward, 20 μL of a freshly prepared CL substrate mixture
(10 μL of 20 mM luminol and 10 μL of 10 mM H2O2) was added to collect the CL images using a CCD with
an exposure time of 30 s. Spots were automatically identified using
VisionWorksLS image acquisition and analysis software (UVP, USA).
The CL intensity of each spot was calculated as the mean pixel intensity
within a circle of a given radius.
Results and Discussion
Antigen-Induced
Formation of the G4/Hemin DNAzyme
In
this work, a circular DNA, a pair of DNA–antibody conjugates
(Ab-1 and Ab-2), a blocked primer (block/primer complex), and a phi
29 polymerase were mixed with the sample to perform target protein
recognition and signal amplification (Scheme A). The circular DNA was prepared in advance
via ligating of a G4-padlock with a primer and removing the hybridized
primer through the cleavage behavior of Exo III (Scheme B). In the presence of the
SARS-CoV-2 protein, the antibodies Ab1 and Ab2 in Ab-1 and Ab-2 recognized
the protein to draw the DNA strands closer, which induced the generation
of a proximity-ligated complex (named as Ab-1/SARS-CoV-2/Ab-2). Thus,
the primer could be released from the block/primer complex via a strand
displacement reaction, which triggered the RCA to produce a large
amount of G4 duplicate sequences, leading to the formation of abundant
DNAzyme units in the presence of hemin. Owing to the excellent catalytic
ability of the DNAzyme to the oxidation of luminol by hydrogen peroxide,
the amplified CL signal could be generated for sensitive detection
of the SARS-CoV-2 protein in serum samples.
Scheme 1
Schematic Diagrams
of (A) CL Imaging for Detection of the SARS-CoV-2
Protein and (B) Preparation of Circular DNA
Characterization of Circular DNA
The formation of circular
DNA was verified by CL imaging and TDS measurements. As shown in Figure A with the CL intensity
range from 0 to 65,000, after the mixture of 0.75 μL of 100
pM primer, 2.25 μL of the RCA reaction solution, and 1.75 μL
of 10 mM PBS was incubated and then mixed with hemin in PBS (10 mM)
solution to perform CL imaging, a very weak CL signal could be observed,
However, the presence of the obtained circular DNA led to a strong
CL signal, indicating the successful triggering of RCA by the primer
to produce G4 sequences. Compared to the flat TDS curve of the reaction
mixture in the absence of circular DNA, which implied that no G4 existed
in the mixture, the presence of circular DNA showed a sharp peak around
260 nm and a negative peak at 295 nm for the G4 structure (Figure B), further demonstrating
the necessity of circular DNA for the formation of G4 sequences.
Figure 1
(A) CL
intensity and (B) thermal difference spectra (TDS) for the
mixture of 0.75 μL of 100 pM primer, 2.25 μL of the RCA
reaction solution, and 1.75 μL of 10 mM PBS in absence (a) or
presence (b) of 0.5 μL of circular DNA. (C) PAGE (left) and
protein silver staining (right) of DNA 1 (1), Ab1 (2), DNA 1 + Ab1
(3), and Ab-1 (4).
(A) CL
intensity and (B) thermal difference spectra (TDS) for the
mixture of 0.75 μL of 100 pM primer, 2.25 μL of the RCA
reaction solution, and 1.75 μL of 10 mM PBS in absence (a) or
presence (b) of 0.5 μL of circular DNA. (C) PAGE (left) and
protein silver staining (right) of DNA 1 (1), Ab1 (2), DNA 1 + Ab1
(3), and Ab-1 (4).
Characterization of DNA–Antibody
Conjugates
As shown in Figure C, the strip of DNA 1 occurred at the same position
in the lands
loading DNA 1 and the mixture of DNA 1 and Ab1, indicating the absence
of binding between DNA 1 and Ab1. Ab1 did not show its strip by staining
with a nucleic acid dye. After DNA 1 was covalently bound with Ab1
using MBS as a biofunctional connector, the strip of Ab-1 showed much
slower migration than DNA 1. The migration rate was similar to those
observed for Ab1 and the mixture of DNA 1 and Ab1, indicating the
successful preparation of DNA–antibody conjugates.
Feasibility
of CL Imaging Assay for SARS-CoV-2
Both
the RCA reaction solution and its mixture with circular DNA showed
a very weak CL signal after they were incubated with hemin to perform
the CL imaging (Figure a,b). The weak signal could be attributed to the slow oxidation of
luminol by H2O2. After the primer was introduced
into the mixture of the RCA reaction solution with circular DNA, a
strong CL signal could be obtained (Figure c), indicating the formation of a G4/hemin
DNAzyme to catalyze the oxidation reaction. However, the introduction
of the block/primer complex into the mixture of the RCA reaction solution
with circular DNA did not produce an obvious CL signal (Figure d), indicating the blocking
of the primer by the block DNA. Moreover, the introduction of Ab-1
and Ab-2 without the presence of the target protein did not change
the signal intensity (Figure e). The weak CL signal could be considered as the background
or noise. After the SARS-CoV-2 protein was added in the mixture of
Ab-1, Ab-2, the block/primer, circular DNA, and the RCA reaction solution
to incubate for 2 h at 37 °C and then mixed with hemin to incubate
in the dark for 20 min, the strong CL signal could be observed (Figure f), the same as the
primer introduction in the mixture of the RCA reaction solution with
the circular DNA primer, leading to an amplified CL method for detection
of the SARS-CoV-2 protein.
Figure 2
CL signals of (a) RCA reaction solution, (b)
a + 0.5 μL of
circular DNA, (c) b + 0.5 μL of 100 pM primer, (d) b + 0.5 μL
of 10 nM block/primer, (e) d + 0.5 μL of 10 ng/mL Ab-1 + 0.5
μL of 10 ng/mL Ab-2, and (f) e + 0.75 μL of 20 pg/mL SARS-CoV-2
protein.
CL signals of (a) RCA reaction solution, (b)
a + 0.5 μL of
circular DNA, (c) b + 0.5 μL of 100 pM primer, (d) b + 0.5 μL
of 10 nM block/primer, (e) d + 0.5 μL of 10 ng/mL Ab-1 + 0.5
μL of 10 ng/mL Ab-2, and (f) e + 0.75 μL of 20 pg/mL SARS-CoV-2
protein.
Optimization of Detection
Conditions
The concentration
of hemin was a vital factor affecting the detection performance. Little
hemin led to a low CL signal difficult to detect for observation,
while too much hemin caused a high background. As shown in Figure A, the CL signal
increased with the increasing concentration of hemin, which also resulted
in increasing background. The maximum signal-to-noise ratio occurred
for the hemin concentrations of 2 to 5 μM. Thus, 5 μM
hemin was used as the optimal condition to obtain high sensitivity.
In addition, the RCA time determined the length of the product chain
and thus influenced the catalytic efficiency and CL intensity. The
CL intensity increased with the increasing incubation time, and the
signal-to-noise ratio tended to a maximum value after incubation for
2.0 h (Figure B),
which was selected to perform simultaneous proximity hybridization,
strand displacement reaction, and RCA.
Figure 3
CL signals and signal-to-noise
ratios at different hemin concentrations
(A) and reaction times (B).
CL signals and signal-to-noise
ratios at different hemin concentrations
(A) and reaction times (B).Under the optimal conditions,
the performance of CL imaging assay was first evaluated with primer-triggered
RCA. As expected, the CL intensity increased with the increasing concentration
of the primer, and the plot of the CL signal versus the logarithm
of primer concentration showed good linearity in the range concentrations
from 0.01 to 500 pM with the correlation coefficient of 0.9983 (Figure ). This result guaranteed
the feasibility of quantitative analysis for the target protein through
proximity hybridization and primer-triggered RCA.
Figure 4
CL signals at 0.01, 0.05,
0.5, 1, 5, 50, 100, and 500 pM primer
and the plot of the CL signal vs the logarithm of primer concentration.
CL signals at 0.01, 0.05,
0.5, 1, 5, 50, 100, and 500 pM primer
and the plot of the CL signal vs the logarithm of primer concentration.
Analytical Performance of CL Assay to the
SARS-CoV-2 Protein
The concentrations of Ab-1 and Ab-2 had
an impact on the CL signal
and the detection range. At different concentrations of Ab-1 and Ab-2,
the CL intensity increased and then decreased with the increasing
concentration of the SARS-CoV-2 protein (Figure A). The signal decrease was caused by the
Hook effect.[36] Considering the widest detection
range and the appropriate sensitivity, 10 ng/mL DNA–antibody
conjugates were chosen.
Figure 5
(A) CL imaging at different SARS-CoV-2 concentrations
detected
with 10, 100, 1000, and 10,000 ng/mL Ab-1 and Ab-2. (B) CL signals
at 0.02, 0.05, 0.2, 0.5, 2, 5, 20, and 100 pg/mL SARS-CoV-2 and the
corresponding calibration curve. (C) CL responses to 20 pg/mL PCSK9,
PSA, AFP, SARS-CoV-2, CEA, BSA, and PBS.
(A) CL imaging at different SARS-CoV-2 concentrations
detected
with 10, 100, 1000, and 10,000 ng/mL Ab-1 and Ab-2. (B) CL signals
at 0.02, 0.05, 0.2, 0.5, 2, 5, 20, and 100 pg/mL SARS-CoV-2 and the
corresponding calibration curve. (C) CL responses to 20 pg/mL PCSK9,
PSA, AFP, SARS-CoV-2, CEA, BSA, and PBS.Under the optimal conditions, the CL intensity increased with the
increasing concentration of the SARS-CoV-2 protein from 0.02 to 100
pg/mL (Figure B),
and the plot of the CL signal versus the logarithm of the SARS-CoV-2
protein concentration showed good linearity with a linear equation
of I = 8.3 log c + 29.8. The limit
of detection was estimated to be 6.46 fg/mL (3Sb/m, where Sb is
the standard deviation of the blank signal (n = 20)
and m is the slope of the calibration curve). This
remarkable sensitivity of the proposed CL assay was attributed to
the large amount of G4 sequences produced in RCA. The selectivity
of this CL assay for the SARS-CoV-2 protein was confirmed by comparing
the CL signals in the presence of different proteins, including PCSK9,
PSA, AFP, CEA, and BSA. As expected, these proteins did not show a
significant signal in comparison with the blank, while the target
showed an extremely increased signal (Figure C), which demonstrated that these proteins
did not interfere with the detection and the proposed method had excellent
specificity.
Real Sample Analysis
Recovery experiments
were applied
to examine the accuracy of SARS-CoV-2 protein analysis by mixing various
concentrations of the SARS-CoV-2 protein with human serum samples.
As shown in Table , the recovery rate ranged from 80.0 to 91.4%, which indicated the
acceptable reliability of this method.
Table 1
Detection
Results of the SARS-CoV-2
Protein Added in Serum Samples
number
added (pg/mL)
measured (pg/mL)
recovery (%)
1
0.02
0.016
80.0
2
0.5
0.436
87.2
3
5
4.57
91.4
4
100
83.2
83.2
The sensitivity of the CL imaging
method was further evaluated
with the SARS-CoV-2 vaccine. Different concentrations of the SARS-CoV-2
vaccine were detected using both commercial GICA and CL assay. As
shown in Figure A,
in the absence of the SARS-CoV-2 vaccine, the GICA assay displayed
only a red band at the top, which demonstrated that the test result
was negative. After 290 or 580 pg/mL SARS-CoV-2 vaccine was introduced
into the detection solution, no new band occurred on the test paper.
The existence of 5.8 ng/mL SARS-CoV-2 vaccine resulted in a slight
red band at the bottom of the test paper, which got darker at a concentration
of 58 ng/mL. However, the suggested method showed the CL signal at
the SARS-CoV-2 vaccine concentrations lower than 0.58 pg/mL (Figure B), indicating obviously
higher sensitivity in comparison with the GICA assay.
Figure 6
(A) GICA test of the
SARS-CoV-2 vaccine at 58,000, 5800, 580, 290,
and 0 pg/mL. (B) CL detection of the SARS-CoV-2 vaccine with the proposed
method at 0, 0.58, 5.8, 58, and 5.8 × 105 pg/mL.
(A) GICA test of the
SARS-CoV-2 vaccine at 58,000, 5800, 580, 290,
and 0 pg/mL. (B) CL detection of the SARS-CoV-2 vaccine with the proposed
method at 0, 0.58, 5.8, 58, and 5.8 × 105 pg/mL.
Conclusions
A highly sensitive CL
imaging system for quantitative detection
of the SARS-CoV-2 protein has been proposed by target-induced formation
of a G4/hemin DNAzyme. The homogeneous CL imaging procedure can be
conveniently performed by mixing the sample with a pair of DNA–antibody
conjugates, a circular DNA, a block/primer complex, and a RCA reaction
solution to simultaneously trigger proximity hybridization, strand
displacement reaction, and RCA, which produces a large amount of G4
duplicate sequences for forming abundant horseradish peroxidase-like
DNAzyme units in the presence of hemin. The amplified CL imaging method
for the SARS-CoV-2 protein shows a wide concentration range along
with a fg/mL-level detection limit and good selectivity. Owing to
the advantages of CL analysis and intrinsic high throughput of the
imaging technique, the proposed CL assay possesses the potential applicability
in early screening and prompt diagnosis of the SARS-CoV-2 disease.
Authors: Joachim Mariën; Ann Ceulemans; Johan Michiels; Leo Heyndrickx; Karen Kerkhof; Nikki Foque; Marc-Alain Widdowson; Laure Mortgat; Els Duysburgh; Isabelle Desombere; Hilde Jansens; Marjan Van Esbroeck; Kevin K Ariën Journal: J Virol Methods Date: 2020-11-20 Impact factor: 2.014
Authors: Ali H Elmokadem; Nihal M Batouty; Dalia Bayoumi; Basma N Gadelhak; Rihame M Abdel-Wahab; Mona Zaky; Sherif A Abo-Hedibah; Ahmed Ehab; Ahmed El-Morsy Journal: Insights Imaging Date: 2021-02-03